| Kozhikode Veetil Narayanan Menon, MD, MB, BS | |
|
1001 E 21st St, Suite 303, Sioux Falls, SD 57105-1033 | |
| (605) 322-8535 | |
| (605) 322-8536 |
| Full Name | Kozhikode Veetil Narayanan Menon |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 36 Years |
| Location | 1001 E 21st St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134191869 | NPI | - | NPPES |
| C70501051883 | Other | SD | PREFERRED ONE |
| 8G872ME | Other | MN | CC SYSTEMS/ BLUE PLUS |
| 2900749 | Other | SD | MEDICA |
| 57105N004 | Other | SD | WPS TRICARE |
| HP31651 | Other | SD | HEALTHPARTNERS |
| 4992979 | Other | SD | BLUE CROSS |
| 6631900 | Medicaid | SD | |
| 1134191869 | Other | ARAZ/AMERICA'S PPO | |
| 1134191869 | Medicaid | IA | |
| 751117500 | Medicaid | MN | |
| 10025567100 | Medicaid | NE | |
| 7010 | Other | SD | DAKOTACARE |
| 253800 | Other | SD | MIDLANDS CHOICE |
| 8G872ME | Other | MN | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 43331 (Minnesota) | Secondary |
| 207RI0008X | Internal Medicine - Hepatology | 7010 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical City Transplant Pllc | 6709176654 | 9 |
News Archive
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.
Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.
A recent preclinical study led by Anja Kipar of the University of Zurich and the University of Liverpool found evidence of the virus infecting and eventually provoking cell death in microglia and immune cells — but not neurons. The viral-induced apoptosis in these brain cells may explain why some long-haulers experience ‘brain fog' months after recovery.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 1 days ago
| Entity Name | Medical City Transplant Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396107819 PECOS PAC ID: 6709176654 Enrollment ID: O20160606000032 |
News Archive
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.
Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.
A recent preclinical study led by Anja Kipar of the University of Zurich and the University of Liverpool found evidence of the virus infecting and eventually provoking cell death in microglia and immune cells — but not neurons. The viral-induced apoptosis in these brain cells may explain why some long-haulers experience ‘brain fog' months after recovery.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kozhikode Veetil Narayanan Menon, MD, MB, BS Po Box 86370, Sioux Falls, SD 57118-6370 Ph: (605) 322-8535 | Kozhikode Veetil Narayanan Menon, MD, MB, BS 1001 E 21st St, Suite 303, Sioux Falls, SD 57105-1033 Ph: (605) 322-8535 |
News Archive
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.
Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.
A recent preclinical study led by Anja Kipar of the University of Zurich and the University of Liverpool found evidence of the virus infecting and eventually provoking cell death in microglia and immune cells — but not neurons. The viral-induced apoptosis in these brain cells may explain why some long-haulers experience ‘brain fog' months after recovery.
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 1 days ago
Jaroslaw Mateuszczyk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-328-8188 | |
Aaron Burkhardt, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6100 S Louise Ave Ste 1120, Sioux Falls, SD 57108 Phone: 605-504-1700 | |
Curtis Blake Rexroth, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-8000 | |
Vinod Parameswaran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E. 23rd St., Ste. 200, Sioux Falls, SD 57105 Phone: 605-322-3035 Fax: 605-322-3036 | |
Lloyd E Solberg, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 W 18th St, Sioux Falls, SD 57105 Phone: 605-312-2200 | |
Ismail Omran, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-238-8100 | |
Francine Vanessa Arneson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 E. 20th St., Ste. 509, Sioux Falls, SD 57105 Phone: 605-322-8993 |